These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 36797228)
1. circGLS2 inhibits hepatocellular carcinoma recurrence via regulating hsa-miR-222-3p-PTEN-AKT signaling. Chen X; Wu T; Xian L; Ma L; Li N; Liu W; Cai P; Tan X; Yin J; Cao G Signal Transduct Target Ther; 2023 Feb; 8(1):67. PubMed ID: 36797228 [No Abstract] [Full Text] [Related]
2. microRNA-19a-3p promotes tumor metastasis and chemoresistance through the PTEN/Akt pathway in hepatocellular carcinoma. Jiang XM; Yu XN; Liu TT; Zhu HR; Shi X; Bilegsaikhan E; Guo HY; Song GQ; Weng SQ; Huang XX; Dong L; Janssen HLA; Shen XZ; Zhu JM Biomed Pharmacother; 2018 Sep; 105():1147-1154. PubMed ID: 30021351 [TBL] [Abstract][Full Text] [Related]
3. Circ_0004018 suppresses cell proliferation and migration in hepatocellular carcinoma via miR-1197/PTEN/PI3K/AKT signaling pathway. Wang H; Zhang Q; Cui W; Li W; Zhang J Cell Cycle; 2021 Oct; 20(20):2125-2136. PubMed ID: 34570663 [TBL] [Abstract][Full Text] [Related]
4. High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating PTEN/Akt pathway in hepatocellular carcinoma. Yang B; Feng X; Liu H; Tong R; Wu J; Li C; Yu H; Chen Y; Cheng Q; Chen J; Cai X; Wu W; Lu Y; Hu J; Liang K; Lv Z; Wu J; Zheng S Oncogene; 2020 Oct; 39(42):6529-6543. PubMed ID: 32917956 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway. Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-760 Inhibits Doxorubicin Resistance in Hepatocellular Carcinoma through Regulating Notch1/Hes1-PTEN/Akt Signaling Pathway. Tian T; Fu X; Lu J; Ruan Z; Nan K; Yao Y; Yang Y J Biochem Mol Toxicol; 2018 Aug; 32(8):e22167. PubMed ID: 29968951 [TBL] [Abstract][Full Text] [Related]
7. miR-218 modulate hepatocellular carcinoma cell proliferation through PTEN/AKT/PI3K pathway and HoxA10. Xiao ZD; Jiao CY; Huang HT; He LJ; Zhao JJ; Lu ZY; Liu LX Int J Clin Exp Pathol; 2014; 7(7):4039-44. PubMed ID: 25120782 [TBL] [Abstract][Full Text] [Related]
8. MiR-128-3p overexpression sensitizes hepatocellular carcinoma cells to sorafenib induced apoptosis through regulating DJ-1. Guo XL; Wang HB; Yong JK; Zhong J; Li QH Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6667-6677. PubMed ID: 30402839 [TBL] [Abstract][Full Text] [Related]
9. Knockdown of miR-25 increases the sensitivity of liver cancer stem cells to TRAIL-induced apoptosis via PTEN/PI3K/Akt/Bad signaling pathway. Feng X; Jiang J; Shi S; Xie H; Zhou L; Zheng S Int J Oncol; 2016 Dec; 49(6):2600-2610. PubMed ID: 27840896 [TBL] [Abstract][Full Text] [Related]
10. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway. He C; Dong X; Zhai B; Jiang X; Dong D; Li B; Jiang H; Xu S; Sun X Oncotarget; 2015 Oct; 6(30):28867-81. PubMed ID: 26311740 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway. Li WF; Dai H; Ou Q; Zuo GQ; Liu CA Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417 [TBL] [Abstract][Full Text] [Related]
12. miR-185 inhibits hepatocellular carcinoma growth by targeting the DNMT1/PTEN/Akt pathway. Qadir XV; Han C; Lu D; Zhang J; Wu T Am J Pathol; 2014 Aug; 184(8):2355-64. PubMed ID: 24911372 [TBL] [Abstract][Full Text] [Related]
13. AEG-1/miR-221 Axis Cooperatively Regulates the Progression of Hepatocellular Carcinoma by Targeting PTEN/PI3K/AKT Signaling Pathway. Kannan M; Jayamohan S; Moorthy RK; Chabattula SC; Ganeshan M; Arockiam AJV Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31698701 [TBL] [Abstract][Full Text] [Related]
14. Oroxin B Induces Apoptosis by Down-Regulating MicroRNA-221 Resulting in the Inactivation of the PTEN/PI3K/AKT Pathway in Liver Cancer. Li N; Men W; Zheng Y; Wang H; Meng X Molecules; 2019 Nov; 24(23):. PubMed ID: 31801250 [TBL] [Abstract][Full Text] [Related]
15. Hydrazinocurcumin and 5-fluorouracil enhance apoptosis and restrain tumorigenicity of HepG2 cells via disrupting the PTEN-mediated PI3K/Akt signaling pathway. Zhou Y; Zhang M; Zhang Z; Jia Y; Zhang C; Peng L Biomed Pharmacother; 2020 Sep; 129():109851. PubMed ID: 32559627 [TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA TPTEP1 exerts inhibitory effects on hepatocellular carcinoma by impairing microRNA-454-3p-mediated DLG5 downregulation. Dong Y; Wang Q; Sun J; Liu H; Wang H Dig Liver Dis; 2022 Feb; 54(2):268-279. PubMed ID: 34238665 [TBL] [Abstract][Full Text] [Related]
17. In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2. Fornari F; Milazzo M; Chieco P; Negrini M; Marasco E; Capranico G; Mantovani V; Marinello J; Sabbioni S; Callegari E; Cescon M; Ravaioli M; Croce CM; Bolondi L; Gramantieri L J Pathol; 2012 Jul; 227(3):275-85. PubMed ID: 22262409 [TBL] [Abstract][Full Text] [Related]
18. miR-382-5p promotes cell invasion in hepatocellular carcinoma by targeting PTEN to activate PI3K/Akt signaling pathway. Lv B; Liu X; Zhu X; Huang M World J Surg Oncol; 2022 Jun; 20(1):175. PubMed ID: 35655254 [TBL] [Abstract][Full Text] [Related]
19. Curcumin inhibits proliferation of hepatocellular carcinoma cells through down regulation of DJ-1. Han L; Wang Y; Sun S Cancer Biomark; 2020; 29(1):1-8. PubMed ID: 32417759 [TBL] [Abstract][Full Text] [Related]
20. miR-1236 down-regulates alpha-fetoprotein, thus causing PTEN accumulation, which inhibits the PI3K/Akt pathway and malignant phenotype in hepatoma cells. Gao R; Cai C; Gan J; Yang X; Shuang Z; Liu M; Li S; Tang H Oncotarget; 2015 Mar; 6(8):6014-28. PubMed ID: 25714026 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]